Clinical Trial Update: WALTZ - Wet Age-Related Macular Degeneration (AMD) AL-39324 Treatment Examination [Phase 2]

View source ↗

Summary

This document reports a Phase 2 study update for AL-39324 in wet age-related macular degeneration, and notes that the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• AL-39324

Snippet

Sponsor: Alcon Research | Conditions: Age Related Macular Degeneration | Phase 2 | Status: COMPLETED